CBD-Infused Skincare Market

How Big Is the CBD-Infused Skincare Market in 2026?

The global CBD-infused skincare market is valued at USD 1.98 billion in 2026, up from USD 1.78 billion in 2025, and is projected by Future Market Insights (FMI) to reach USD 5.98 billion by 2036, expanding at an 11.7% CAGR from 2026 to 2036 and generating USD 4.00 billion in incremental revenue over the 10-year forecast period.

Table 1: Global CBD-Infused Skincare Market Size, Share, and Forecast Summary (2025 to 2036)

Market Metric	Valuation / Share / Forecast Benchmark
2025 Market Size (Historical)	USD 1.78 billion
2026 Market Size (Estimated)	USD 1.98 billion
2036 Market Size (Projected)	USD 5.98 billion
Compound Annual Growth Rate (2026 to 2036)	11.7% CAGR
Incremental Dollar Opportunity (2026 to 2036)	USD 4.00 billion
Dominant Product Type (2026 to 2036 Share)	Creams and Lotions (49.5% in 2026, falling to 46.0% by 2036)
Leading & Fastest-Growing Variants	Anti-inflammatory (53.5% share in 2026; 11.0% CAGR) | Acne and Blemish Care (13.4% CAGR)
Leading & Fastest-Growing Channels	E-commerce (41.0% share in 2026; 11.2% CAGR) | Pharmacies (13.6% CAGR)
Largest Country Markets (2026 Global Share)	United States (38.0%), United Kingdom (9.0%), Germany (6.0%)
Fastest-Growing Country Markets (2026 to 2036)	India (22.0% CAGR), Japan (17.2% CAGR), United Kingdom (14.0% CAGR)
Leading Tier-1 Companies	Charlotte's Web, cbdMD, CBDfx

Source: Future Market Insights analysis of the CBD-infused skincare market, 2026.

Executive Market Overview

Demand for CBD-infused skincare covers creams, lotions, serums, oils and balms that contain hemp-sourced cannabidiol and are sold as cosmetics for calming, blemish care, anti-aging and soothing use. Creams and lotions bring in 49.5% of 2026 revenue as the everyday format, and products positioned on anti-inflammatory benefits account for 53.5%. The United States remains the biggest national base but is forecast at only 9.2% a year, whereas India, starting from very low sales, is projected at a 22.0% CAGR through 2036, with Japan at 17.2% and the United Kingdom at 14.0%.

Rule changes in 2025 and 2026 matter more to the forecast than any launch. The EU Scientific Committee on Consumer Safety issued its final opinion on April 24, 2026, finding CBD acceptable at up to 0.19% in dermal and oral cosmetic products and THC impurities at up to 0.00025%. In the United States, Congress enacted new federal limits on hemp products containing THC in November 2025, and brands such as Charlotte's Web and cbdMD are campaigning to protect full-spectrum CBD. China has prohibited CBD in cosmetics since 2021. This report covers topical cosmetic skincare made with hemp-sourced CBD only and excludes ingestible CBD, supplements, THC products and non-cosmetic CBD applications.

Analyst Perspective

"This category has always sold on a promise of calm skin, but its size in any country is set by the regulator before the marketer. Brands that can document cannabinoid purity batch by batch will keep their retail listings, and those that buy hemp extract on the spot market will lose them."

Rahul Pandita, Principal Consultant, Future Market Insights (FMI)

CBD-Infused Skincare Market Definition

CBD-infused skincare comprises topical beauty and personal care products formulated with cannabidiol (CBD) extracted from hemp plants, utilizing its anti-inflammatory, antioxidant, and soothing properties for various skin concerns. These products include creams, lotions, serums, oils, and balms positioned across functional benefits including anti-inflammatory, acne/blemish care, anti-aging, and soothing applications, often combined with clean beauty claims such as natural/organic, vegan, and dermatologist-tested positioning.

CBD-Infused Skincare Market Inclusions

The report includes a comprehensive analysis of market dynamics, featuring Global and Regional Market Sizes (Volume and Value) and a 10-year Forecast (2026-2036). It covers segmental breakdowns by function (Anti-inflammatory, Acne/Blemish Care, Anti-aging, Soothing), product type (Creams/Lotions, Oils, Serums, Balms), channel (E-commerce, Pharmacies, Mass Retail, Specialty Beauty Stores), claim (Natural/Organic, Vegan, Clean-label, Dermatologist-tested), and geographic regions.

CBD-Infused Skincare Market Exclusions

The scope excludes ingestible CBD products, CBD supplements, and non-cosmetic CBD applications. It also omits THC-containing products and cannabis-derived items not meeting hemp-derived CBD standards (<0.3% THC), focusing strictly on topical skincare formulations compliant with regional cosmetic regulations.

CBD-Infused Skincare Market Research Methodology

• Primary Research: Interviews were conducted with CBD skincare manufacturers, beauty retailers, dermatologists, and regulatory consultants across major regions. Extraction technology specialists clarified formulation stability.
• Desk Research: Beauty industry reports, e-commerce platform data, and corporate financial filings supported volume benchmarking.
• Market-Sizing and Forecasting: A hybrid top-down and bottom-up model was developed. Demand was reconstructed from regional beauty market sizes, CBD penetration rates, and category growth trajectories, then validated against manufacturer sales data.
• Data Validation and Update Cycle: Outputs undergo anomaly screening, variance checks across production and trade datasets, and structured peer review prior to release.

Segmental Analysis

CBD-Infused Skincare Market Analysis by Function

Based on FMI’s CBD-infused skincare market report, anti-inflammatory formulations are estimated to hold 53.5% share in 2026. Growth in anti-inflammatory products stems from CBD’s demonstrated ability to calm visible redness, manage irritation, and align with consumer preference for plant-based, wellness-oriented skincare positioned around holistic skin health and barrier repair.

• Consumer-Led Clinical Positioning: CBDfx emphasized rising consumer demand for botanical wellness solutions, stating, “More than ever before, consumers are searching for plant-based solutions that promote holistic health, and at the top of that list is CBD oil. Whether you're searching for the best CBD oil for anxiety, stress relief, focus, or recovery, this advanced CBD and CBG combo is designed to deliver noticeable results.” [2]
• Acne-Focused Dermatological Claims: Kiehl’s highlighted irritation-calming functionality in its CBD positioning, noting that the formulation “Helps visibly reduce skin redness and provides skin with relief from discomfort. Non-acnegenic formula can be used on problem and blemish-prone skin.” [3]
• Barrier and Sensitivity Alignment: Anti-inflammatory CBD positioning increasingly intersects with microbiome-friendly and non-comedogenic claims, reinforcing its role in sensitive skin regimens where redness management and daily calming efficacy are prioritized.

CBD-Infused Skincare Market Analysis by Product Type

Based on FMI’s CBD-infused skincare market report, creams and lotions are estimated to hold 49.5% share in 2026. Growth in this segment is driven by their role as daily-use essentials, compatibility with layered skincare routines, and increasing penetration into mass retail and specialty beauty distribution channels.

• Mass Retail Acceleration: Retail expansion has strengthened category visibility, with the product range described as including “a CBD Replenishing Moisture Cream, Restoring Face Oil and Soothing Oil-Balm Cleansing Mask, suitable for all skin types, available at Ulta Beauty.” [4]
• Portfolio Diversification Strategy: Industry review coverage noted strategic positioning shifts, stating, “Predictive, Protective, Planet-Positive: Redefining Hair Care and Skincare for 2026. The Natura &Co-owned brand's Founder Dame Anita Roddick was a trailblazer when she ushered in the Hemp collection and the ethical beauty line is now embracing the CBD trend.” [5]
• Daily-Use Integration Advantage: Cream and lotion formats remain structurally advantaged due to established consumer routines, enabling CBD infusion without requiring behavior change, thereby accelerating adoption compared to niche formats such as masks or targeted treatments.

CBD-Infused Skincare Market Drivers, Restraints, and Opportunities

Future Market Insights analysis indicates that historical patterns point to a transition-stage global industry where CBD-infused skincare has moved from novelty positioning to structured premium wellness adoption. Estimated valuation in 2026 reflects an ongoing “regulatory clarity and retail normalization push,” as brands invest in compliant sourcing, third-party testing, and clinically backed positioning to build consumer trust in cannabinoid-based formulations.

While consumer curiosity around CBD remains strong (volume support), regulatory ambiguity across certain jurisdictions and fragmented labeling standards constrain rapid mass-market penetration (volume friction). At the same time, price-per-unit for CBD-infused formulations remains structurally higher than conventional botanical skincare (value uplift), resulting in steady but premium-skewed growth. The forecast assumes the market enters a “credibility consolidation” phase where only brands with transparent supply chains, verified cannabinoid content, and dermatologist-aligned claims scale sustainably, while speculative entrants face attrition.

• Wellness Premiumization: Growth is shifting from trend-driven CBD claims to clinically supported anti-inflammatory and barrier-repair positioning, reinforcing CBD’s role in sensitive skin, acne-prone, and stress-reactive skincare categories.
• Regulatory Standardization Pressure: Increasing scrutiny around THC thresholds, labeling transparency, and interstate commerce compliance is pushing brands toward pharmaceutical-grade sourcing, batch testing, and standardized cannabinoid concentrations.
• Retail Channel Expansion: Broader acceptance within specialty beauty chains and select mass retailers is normalizing CBD skincare as a routine wellness product, accelerating daily-use formats such as creams and serums while reinforcing premium pricing power.

Regional Analysis

Based on the regional analysis, the CBD-infused skincare market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa across 40+ countries. The full report also offers market attractiveness analysis based on regulatory normalization, cannabinoid safety thresholds, retail acceptance, and evolving cosmetic compliance frameworks.

Country	CAGR (2026 to 2036)
India	22.0%
China	20.5%
Japan	17.2%
United Kingdom	14.0%
Germany	10.2%
United States	9.2%
Brazil	8.5%

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research

North America CBD-Infused Skincare Market Analysis

North America is characterized by regulatory formalization and safety substantiation, where CBD skincare growth is increasingly tied to compliance documentation, facility registration, and ingredient transparency requirements. The implementation of MoCRA represents the most significant structural shift in US cosmetic oversight in decades.

• United States: Demand for CBD-infused skincare in the United States is projected to expand at a 9.2% CAGR through 2036. Growth is supported by regulatory clarification under MoCRA, with the US FDA stating, “With the passage of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). FDA has new authorities to help ensure the safety of cosmetic products many consumers use.” [6]

FMI’s report includes detailed analysis of regulatory enforcement timelines, product registration requirements, and safety substantiation obligations across the United States and Canada.

Asia Pacific CBD-Infused Skincare Market Analysis

Asia Pacific represents the fastest-growing region, supported by evolving cannabinoid regulations and structured cosmetic ingredient oversight. Markets are transitioning from prohibition or ambiguity toward defined THC thresholds and safety frameworks.

• Japan: Demand in Japan is projected to rise at a 17.2% CAGR through 2036, supported by clarified cannabinoid regulations. The Ministry of Health, Labour and Welfare confirmed that “The new regulations on cannabinoid (CBD) products are now expected to come into effect. Products likely to be subject to the 1 ppm threshold include Shampoos, conditioners, lotions, creams.” [7]
• China: China’s 20.5% CAGR reflects regulatory modernization in cosmetic oversight, with the NMPA notifying new cosmetic ingredients and revising multiple testing standards, reinforcing stricter compliance for ingredient registration and evaluation. [8]
• India: India leads South Asia with a projected 22.0% CAGR, supported by structured oversight under the Drugs & Cosmetics Act, 1940, which governs Ayurvedic and cosmetic production to “promote the production and export of quality products including cosmetics.” [9]

The full report analyzes cannabinoid regulatory updates, ingredient approval pathways, and retail normalization across Japan, China, India, South Korea, ASEAN, and Oceania.

Latin America CBD-Infused Skincare Market Analysis

Latin America is emerging as both a regulatory reform region and a cultivation-linked supply base, with Brazil leading structured legalization and administration expansion for cannabis-derived products.

• Brazil: A projected 8.5% CAGR through 2036 is supported by ANVISA’s RDC No. 1.015/2026, which expanded permitted administration routes and authorized cultivation of cannabis for medicinal and pharmaceutical purposes, reinforcing structured market development for dermal cosmetic applications. [10]

The report includes detailed assessment of regulatory restructuring, cultivation frameworks, and cross-border commercialization in Brazil, Mexico, Argentina, Chile, and Rest of Latin America.

Europe CBD-Infused Skincare Market Analysis

Europe functions as a regulatory harmonization hub, where CBD concentration thresholds and THC impurity limits are increasingly standardized under scientific review frameworks and statutory amendments.

• United Kingdom: Demand in the United Kingdom is projected to expand at a 14.0% CAGR through 2036, shaped by amendments introduced under Statutory Instrument SI 2026/23, which updates retained cosmetic regulation frameworks and strengthens compliance enforcement. [11]
• Germany (EU Context): Germany’s 10.2% CAGR reflects EU-level safety review processes, with the Scientific Committee on Consumer Safety stating that CBD is considered safe at specified concentration thresholds in dermal cosmetic products, while THC impurities must remain below defined limits. [12]

FMI’s analysis of the European CBD-infused skincare market includes country-wise assessment covering Germany, the United Kingdom, France, Italy, Spain, Nordic countries, Benelux, and Rest of Europe, with emphasis on harmonized safety thresholds, ingredient notifications, and compliance-driven retail expansion.

Competitive Aligners for Market Players

Market structure in CBD-infused skincare appears crowded at the surface level, yet scalable competition is concentrated among brands capable of translating cannabinoid science into dermatologist-aligned, consumer-safe formulations. Many emerging brands rely on white-label manufacturers, but sustainable growth is increasingly controlled by players with in-house R&D, stable hemp supply agreements, and documented regulatory compliance frameworks. The dominant competitive variable is trust-building through quality assurance and clinical positioning rather than aggressive promotional pricing.

Producers with established extraction partnerships and standardized cannabinoid inputs mitigate formulation inconsistency and potency drift. Non-integrated brands dependent on spot hemp sourcing face greater exposure to supply disruptions, regulatory reinterpretations, and shifting retail acceptance policies. As scrutiny around labeling accuracy intensifies, testing documentation and ingredient traceability function as market filters.

Retail consolidation enhances buyer influence. Major chains prioritize brands that can guarantee compliant labeling, scalable inventory, and clear differentiation in anti-inflammatory and barrier-support claims, compressing margins for smaller entrants lacking operational scale or clinical validation.

Recent Developments:

• In February 2026, Cronos Group launched its premium Lord Jones® cannabis brand in Israel, introducing five indoor-grown flower strains to medical patients as part of its international, borderless growth strategy [13].
• In January 2026, At CES, L’Oréal, Samsung, Amorepacific and Kiehl’s showcased AI-powered beauty innovations, from infrared hair tools and LED masks to smart mirrors and wearable skin sensors for personalized skincare [14].

Key Players in CBD-Infused Skincare Market

• CBDfx
• Kiehl's (L'Oréal S.A.)
• Lord Jones
• Cannuka
• Elixinol
• Endoca
• Charlotte's Web, Inc.
• Medterra
• Vertly
• The Body Shop International Limited
• Kiehl's Since 1851
• Josie Maran Cosmetics
• Saint Jane Beauty
• Prima
• Sagely Naturals
• CBD For Life
• Leef Organics
• Myaderm
• PureKana
• CBDistillery

Scope of the Report

Metric	Value
Quantitative Units	USD 1,982.1 million (2026) to USD 5,982.1 million (2036), at a CAGR of 11.7%
Market Definition	The CBD-infused skincare market comprises the global production and trade of topical beauty and personal care products formulated with hemp-derived cannabidiol (CBD), positioned for anti-inflammatory, acne/blemish care, anti-aging, and soothing applications. These products are distributed across mass retail, pharmacy, specialty beauty, and e-commerce channels under cosmetic regulatory frameworks that restrict THC content and require ingredient transparency.
Function Segmentation	Anti-inflammatory, Acne/Blemish Care, Anti-aging, Soothing
Product Type Segmentation	Creams and Lotions, Oils, Serums, Balms
Channel Segmentation	E-commerce, Pharmacies, Mass Retail, Specialty Beauty Stores
Claim Segmentation	Natural/Organic, Vegan, Clean-label, Dermatologist-tested
Regions Covered	North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa
Countries Covered	United States, Canada, Mexico, Brazil, Argentina, Germany, United Kingdom, France, Italy, Spain, China, India, Japan, South Korea, Australia, Thailand, Singapore, Malaysia, UAE, Saudi Arabia and 40+ countries
Key Companies Profiled	Charlotte’s Web Holdings, Inc.; CBDfx; Kiehl’s (L’Oréal S.A.); Lord Jones; Cannuka; Elixinol; Endoca; Medterra; The Body Shop International Limited; Josie Maran Cosmetics; Saint Jane Beauty; Prima; Sagely Naturals; CBD For Life; Leef Organics; Myaderm; PureKana; CBDistillery
Forecast Period	2026 to 2036
Approach	Hybrid top-down and bottom-up market modeling validated through primary interviews with CBD skincare manufacturers, dermatologists, beauty retailers, and regulatory consultants, supported by e-commerce sales benchmarking, retail channel audits, and manufacturer revenue verification.

CBD-Infused Skincare Market Analysis by Segments

Function:

• Anti-inflammatory
  • Redness Reduction
  • Irritation Soothing
  • Skin Calming
• Acne/Blemish Care
  • Spot Treatment
  • Oil Control
  • Pore Clarifying
• Anti-aging
  • Wrinkle Reduction
  • Firming
  • Hydration
• Soothing
  • Sensitivity Relief
  • Post-Treatment Care

Product Type:

• Creams and Lotions
  • Daily Moisturizers
  • Night Creams
  • Body Lotions
• Oils
  • Face Oils
  • Body Oils
• Serums
  • Concentrated Treatments
  • Spot Serums
• Balms
  • Lip Balms
  • Body Balms
  • Targeted Treatments

Channel:

• E-commerce
  • Direct-to-Consumer
  • Online Marketplaces
• Pharmacies
  • Chain Pharmacies
  • Independent Pharmacies
• Mass Retail
  • Supermarkets
  • Big Box Retailers
• Specialty Beauty Stores
  • Sephora/Ulta
  • Beauty Boutiques

Claim:

• Natural/Organic
• Vegan
• Clean-label
• Dermatologist-tested

Region:

• North America
  • United States
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Argentina
  • Chile
  • Colombia
  • Rest of Latin America
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Nordic
  • Benelux
  • Rest of Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia & Pacific
  • India
  • Thailand
  • Singapore
  • Malaysia
  • Australia
  • New Zealand
  • Rest of South Asia & Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Bibliography

• cbdMD via Barchart. (2026). cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access. https://www.barchart.com/story/news/3452343/cbdmd-supports-the-bipartisan-lawful-hemp-protection-act-to-protect-consumers-and-full-spectrum-cbd-access
• CIRS Group. (2026, May 7). SCCS Issued Final Opinion on Cannabidiol (CBD) Used in Cosmetic Products. https://www.cirs-group.com/en/cosmetics/sccs-issued-final-opinion-on-cannabidiol-cbd-used-in-cosmetic-products
• CosmeticsDesign-Europe. (2021, June 14). China CBD ban: Retailers 'encouraged' to pull products off shelves as regulators formally ban use in cosmetics. https://cosmeticsdesign-europe.com/Article/2021/06/14/China-CBD-ban-Retailers-encouraged-to-pull-products-off-shelves-as-regulators-formally-ban-use-in-cosmetics
• European Commission, Scientific Committee on Consumer Safety. (2026). SCCS - Scientific opinion on Cannabidiol (CBD) (CAS/EC No. 13956-29-1/689-176-3) used in cosmetic products. https://health.ec.europa.eu/publications/sccs-scientific-opinion-cannabidiol-cbd-casec-no-13956-29-1-689-176-3-used-cosmetic-products_en
• NC Newsline. (2025, November 14). 'We can't really pivot': North Carolina hemp stores, farms prepare to fight federal ban. https://ncnewsline.com/2025/11/14/we-cant-really-pivot-north-carolina-hemp-stores-farms-prepare-to-fight-federal-ban/
• Saul Ewing. (2025). Congress Enacts Hemp THC Products Ban: What the New Federal Restrictions Mean for the Industry. https://www.saul.com/insights/alert/client-update-congress-enacts-hemp-thc-products-ban-what-new-federal-restrictions

This Report Addresses

• Market intelligence to enable structured strategic decision-making across mature and emerging CBD-infused skincare markets
• Market size estimation and 10-year revenue forecasts from 2026 to 2036, supported by validated beauty retail data and manufacturer sales statistics
• Growth opportunity mapping across functions, product types, channels, and claims with emphasis on anti-inflammatory and clinical formulations
• Segment and regional revenue forecasts covering creams, serums, oils, and balms across all major regions
• Competition strategy assessment including clinical validation, claim depth, and retail channel positioning benchmarking
• Technology roadmap tracking including formulation stability, bioavailability enhancement, and active ingredient synergy
• Regulatory impact analysis covering FDA/EU cosmetic regulations, THC limits, and cross-border compliance requirements
• Market report delivery in PDF, Excel, PPT, and interactive dashboard formats for executive and operational use